The Science Behind Velura
We don't ask you to trust us. We ask you to trust the research.
Every claim we make about the Velura Iris traces back to published, peer-reviewed clinical literature. Here is what the science says — and how we built our product around it.
Understanding the Problem
Why your eyes feel dry, tired, and irritated
Most chronic dry eye is not caused by a lack of tears. It is caused by tears that evaporate too quickly — because the oil layer that should protect them is not doing its job.
That oil is produced by tiny glands in your eyelids called Meibomian glands. When these glands become blocked — through screen use, ageing, or environmental factors — the oil thickens and stops flowing. Your tear film breaks down faster than your body can replace it.
This is known as Meibomian Gland Dysfunction, or MGD — the leading cause of evaporative dry eye disease and the most common form of dry eye worldwide.
The Science of Temperature
Why 40°C is the number that matters
In 2019, Dr. Douglas Borchman at the University of Louisville published a study in The Ocular Surface that measured exactly how meibum responds to heat at a molecular level using infrared spectroscopy.
In healthy individuals, heating meibum to 40°C increases lipid fluidity to 90% of its maximum. In MGD patients, where the oil is thicker, 41.5°C is needed to reach the same level. Below these thresholds, the oil does not soften enough to flow naturally.
This was the first study to establish a specific temperature target for eyelid warming therapy. The Velura Iris was designed around this number — our 45°C setting exceeds the threshold and maintains it consistently across your entire session.
Twenty Years of Evidence
The right heat, for the right duration
A 2024 review in Springer Nature's Ophthalmology & Therapy examined twenty years of warm compress clinical trials to determine which protocols actually work.
The findings: every method tested could reach 40°C, but hot towels lost heat rapidly and were ineffective in longer-term studies. Microwavable and self-heating masks retained heat far better and showed consistent improvements in tear stability and gland health.
The pattern across all studies was clear — a single session could improve tear quality, but repeated daily use of 10–15 minutes over weeks produced the most meaningful, lasting results. The review also found that compliance dropped with more complex protocols, making simplicity a critical factor in real-world effectiveness.
Not All Devices Are Equal
58 studies. One clear conclusion.
A 2022 review in Clinical Optometry examined 58 clinical studies across four categories of eyelid warming device to determine whether device type matters.
It does. Basic heated eye coverings improved symptoms in 78% of studies but improved actual gland function in only 44%. Devices delivering combined heat and pressure improved symptoms in 95%, tear stability in 85%, and gland function in 95%.
The gap was not marginal. The Velura Iris was designed to bridge it — delivering sustained therapeutic heat and multi-zone vibration in a single wireless device, at a fraction of the cost of in-office treatments.
Real-World Validation
Confirmed in a randomized controlled trial
A 2024 RCT published in BMC Ophthalmology enrolled 144 patients with MGD-related dry eye across two clinical centres. Half used self-heating warming masks twice daily for 12 weeks; the other half used hot towels on the same schedule.
Both groups improved — confirming that consistent warm compress therapy works. But the trial reinforced what the reviews indicated: purpose-designed warming masks offer more standardised delivery than towels, supporting the daily consistency the literature identifies as essential.
The biggest barrier to effective warm compress therapy is not the science — it is compliance. The Velura Iris was designed with this in mind: wireless, comfortable, and simple enough to use every day.
From Evidence to Engineering
How the Velura Iris maps to the research
The 45°C setting exists because of Borchman's 40°C threshold.
Meibum requires 40–41.5°C to reach therapeutic fluidity. Our 45°C setting meets and maintains this across your entire session.
15-minute sessions align with the most effective clinical protocols.
Lee (2024) found 10–15 minute sessions produced the strongest outcomes. The Velura Iris is designed for exactly this duration.
Multi-zone vibration bridges the gap Bzovey & Ngo identified.
Combined heat and massage improved gland function in 95% of studies versus 44% for heat alone. The Iris delivers vibration across four zones alongside thermal therapy.
Zero-pressure 3D design protects the treatment area.
The Iris rests on your orbital bones — nothing touches your eyelids or eyes during use.
Wireless design supports the compliance the research demands.
Both the Lee review and the BMC trial highlighted compliance as the biggest barrier. The Iris charges via Type-C and requires no preparation.
The Studies
Our clinical references
The Ocular Surface · Elsevier
The optimum temperature for the heat therapy for Meibomian gland dysfunction
The first study to establish a specific temperature target for eyelid warming therapy. Demonstrated that meibum requires heating to 40°C (healthy) or 41.5°C (MGD) to achieve therapeutic fluidity.
Read on PubMed →Ophthalmology & Therapy · Springer Nature
Evidence-Based Strategies for Warm Compress Therapy in Meibomian Gland Dysfunction
A review of twenty years of warm compress studies. Confirmed sustained heat above 40°C for 10–15 minutes daily as the most effective protocol. Hot towels were unable to maintain therapeutic temperatures.
Read on PubMed →Clinical Optometry · Dove Medical Press
Eyelid Warming Devices: Safety, Efficacy, and Place in Therapy
58 clinical studies across all device categories. Basic masks improved gland function in 44% of studies; combined heat and pressure devices achieved 95%.
Read on PubMed Central →BMC Ophthalmology · Springer Nature
Efficacy and safety of disposable eyelid warming masks for dry eye disease due to MGD
A 12-week RCT comparing self-heating masks against hot towels. Validated that purpose-designed masks support the standardised daily delivery essential for lasting results.
Read on Springer Nature →What We Do Not Claim
Transparency matters to us
The Velura Iris is not a medical device. We do not claim it treats, cures, or diagnoses any condition.
What we claim is that its design parameters — temperature range, session duration, zero-pressure architecture, combined heat and vibration — align with findings from published clinical research across multiple peer-reviewed journals. We built it to make the daily warm compress routine eye care professionals already recommend easier, more consistent, and more effective than traditional methods.
If you have a diagnosed eye condition or any concerns about heat therapy, consult your eye care professional before use.
See the research in action
Experience the difference that consistent, research-informed eye care can make.
Shop Velura Iris →The Velura Iris is not a medical device. All clinical references relate to warm compress therapy principles as documented in peer-reviewed literature. Individual results may vary. Always consult your eye care professional for diagnosis and treatment of eye conditions.